Andrew Paul Mazar - Aug 12, 2024 Form 3 Insider Report for ACTUATE THERAPEUTICS, INC. (ACTU)

Role
Chief Operating Officer
Signature
/s/ Paul Lytle, Attorney-in-Fact
Stock symbol
ACTU
Transactions as of
Aug 12, 2024
Transactions value $
$0
Form type
3
Date filed
8/12/2024, 09:47 PM
Previous filing
Apr 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ACTU Common Stock 127K Aug 12, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ACTU Non-Qualified Stock Options Aug 12, 2024 Common Stock 37.4K $2.14 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 27,778 restricted common stock awards that were granted on February 22, 2021, of which, 25% vested on the first anniversary of the grant date and the remaining 75% vests in equal monthly installments during the 36 months following the first anniversary of the grant date.
F2 Includes 40,395 restricted common stock awards that were granted on July 7, 2022, of which, 25% vested on the first anniversary of the grant date and the remaining 75% vests in equal monthly installments during the 36 months following the first anniversary of the grant date.
F3 37,374 non-qualified stock option awards were granted on October 23, 2023, of which, 25% of the option vests on the first anniversary of the grant date and the remaining 75% vests in equal monthly installments during the 36 months following the first anniversary of the grant date.

Remarks:

Exhibit List Exhibit 24 - Power of Attorney